RGNT today
$0.84-$0.30 (-26.34%)close Nov 19, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $1.47
Key levels
Resistance$1.47
Resistance$1.16
Latest news & SEC filings
DealRegentis Biomaterials signs exclusive distribution deal for GelrinC in Israel
DealRegentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership
All RGNT news →About Regentis Biomaterials
Regentis Biomaterials is a regenerative medicine company that develops hydrogel implants for repairing orthopedic tissue. Its main product, GelrinC, is a ready-made implant placed in the knee to treat damage to articular cartilage, and it is cleared for sale in Europe. The company is conducting a clinical study across the United States, Europe and Israel to support approval in the U.S. It is based in Herzliya, Israel.
Based on the company's 20-F filed Feb 24, 2026.
NYSE · Healthcare
REGENTIS BIOMATERIALS LTD. (RGNT)
What Is the Price Target for RGNT?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is RGNT a Buy or Sell Right Now?
Test your own strategy on RGNT
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on RGNT with SEPT’s own market data.
Start Free Trial →Is RGNT Overvalued or Undervalued?
Valuation Verdict
N/A
Methods Used
N/A
Fair Value
$N/A
7
Moat Score
NONE
3/9
Piotroski Score
-13.1
Altman Z-Score
What Is Smart Money Doing with RGNT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →RGNT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-1504.65%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for RGNT
PREVIEWRecent off-exchange (dark pool) prints for RGNT: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:57:16 | $0.84 | 1,000 | $$840 | BUY |
| 20:50:58 | $0.85 | 1,000 | $$846 | BUY |
| 20:43:58 | $0.90 | 1,050 | $$945 | BUY |
| 19:52:10 | $1.01 | 1,570 | $$2K | BUY |
| 19:46:30 | $1.01 | 1,000 | $$1K | BUY |
5 dark pool trades shown · $$5K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for REGENTIS BIOMATERIALS LTD. (RGNT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →RGNT — frequently asked questions
What is RGNT stock price today?
REGENTIS BIOMATERIALS LTD. (RGNT) is at $0.84, down 26.34% (-$0.30) at the Nov 19, 2026 close.
Why is RGNT stock moving today?
Latest RGNT news — Nov 11, 2026: Regentis Biomaterials signs exclusive distribution deal for GelrinC in Israel · Nov 9, 2026: Regentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership
What are RGNT support and resistance levels?
Resistance: $1.16, $1.47, $1.69.
What are insiders doing with RGNT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on RGNT?
Nov 11, 2026: Regentis Biomaterials signs exclusive distribution deal for GelrinC in Israel · Nov 9, 2026: Regentis Biomaterials to sell GelrinC in Israel via AMI Medical Technologies partnership